Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice

Participants: A. Baer, R. Sarmento-Leite, K. Hayashida, G. Sengottuvelu, M. Traina

Discussants: H. Eltchaninoff, P. Genereux, R. Hahn, T. Treibel

Summary

Is early TAVI the right choice for your asymptomatic patients with severe aortic stenosis? In this video, we break down the latest clinical trials, including EARLY TAVR and EVOLVED, to help you navigate the complex decision-making process.

Find out what these studies really tell us about the risks and benefits of early intervention, and how to balance patient preferences, clinical surveillance and your center’s capabilities. Watch it now!

Learning Objectives

To hear more about the recently published outcomes of the asymptomatic TAVI trials
To understand how to synthesise and interpret this important clinical evidence
To translate this understanding into your Heart Team's daily clinical practice

Presentations available when logged in:

The early TAVR trial
The EVOLVED trial
Synthesis - What DO these trials tell us (and what they DO NOT)?

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice

Learning Objectives

Log in or create account for free